These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 37833786)

  • 1. Hippocampal injections of soluble amyloid-beta oligomers alter electroencephalographic activity during wake and slow-wave sleep in rats.
    Hector A; Provost C; Delignat-Lavaud B; Bouamira K; Menaouar CA; Mongrain V; Brouillette J
    Alzheimers Res Ther; 2023 Oct; 15(1):174. PubMed ID: 37833786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NREM sleep as a novel protective cognitive reserve factor in the face of Alzheimer's disease pathology.
    Zavecz Z; Shah VD; Murillo OG; Vallat R; Mander BA; Winer JR; Jagust WJ; Walker MP
    BMC Med; 2023 May; 21(1):156. PubMed ID: 37138290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroligin-1 is altered in the hippocampus of Alzheimer's disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers.
    Dufort-Gervais J; Provost C; Charbonneau L; Norris CM; Calon F; Mongrain V; Brouillette J
    Sci Rep; 2020 Apr; 10(1):6956. PubMed ID: 32332783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps.
    Sajadi A; Provost C; Pham B; Brouillette J
    J Vis Exp; 2016 Aug; (114):. PubMed ID: 27585306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermoneutral temperature exposure enhances slow-wave sleep with a correlated improvement in amyloid pathology in a triple-transgenic mouse model of Alzheimer's disease.
    Wang J; Huffman D; Ajwad A; McLouth CJ; Bachstetter A; Kohler K; Murphy MP; O'Hara BF; Duncan MJ; Sunderam S
    Sleep; 2024 Jun; 47(6):. PubMed ID: 38512801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the Tuberomammillary Nucleus by GABA
    Xie JF; Fan K; Wang C; Xie P; Hou M; Xin L; Cui GF; Wang LX; Shao YF; Hou YP
    Neurochem Res; 2017 Aug; 42(8):2314-2325. PubMed ID: 28365867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal stem cells promotes synaptic resistance to the dysfunctional impact of amyloid beta oligomers via secreted exosomes.
    Micci MA; Krishnan B; Bishop E; Zhang WR; Guptarak J; Grant A; Zolochevska O; Tumurbaatar B; Franklin W; Marino C; Widen SG; Luthra A; Kernie SG; Taglialatela G
    Mol Neurodegener; 2019 Jun; 14(1):25. PubMed ID: 31200742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional relationships between sleep and amyloid-beta in the hippocampus.
    Dufort-Gervais J; Mongrain V; Brouillette J
    Neurobiol Learn Mem; 2019 Apr; 160():108-117. PubMed ID: 29908972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease.
    Lucey BP; McCullough A; Landsness EC; Toedebusch CD; McLeland JS; Zaza AM; Fagan AM; McCue L; Xiong C; Morris JC; Benzinger TLS; Holtzman DM
    Sci Transl Med; 2019 Jan; 11(474):. PubMed ID: 30626715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-Specific Retinal and Cerebral Immunodetection of Amyloid-β Plaques and Oligomers in a Rodent Model of Alzheimer's Disease.
    Habiba U; Merlin S; Lim JKH; Wong VHY; Nguyen CTO; Morley JW; Bui BV; Tayebi M
    J Alzheimers Dis; 2020; 76(3):1135-1150. PubMed ID: 32597800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer's disease pathology.
    Roh JH; Huang Y; Bero AW; Kasten T; Stewart FR; Bateman RJ; Holtzman DM
    Sci Transl Med; 2012 Sep; 4(150):150ra122. PubMed ID: 22956200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local experience-dependent changes in the wake EEG after prolonged wakefulness.
    Hung CS; Sarasso S; Ferrarelli F; Riedner B; Ghilardi MF; Cirelli C; Tononi G
    Sleep; 2013 Jan; 36(1):59-72. PubMed ID: 23288972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the early stages of Alzheimer's disease by administering intracerebroventricular injections of human native Aβ oligomers to rats.
    Baerends E; Soud K; Folke J; Pedersen AK; Henmar S; Konrad L; Lycas MD; Mori Y; Pakkenberg B; Woldbye DPD; Dmytriyeva O; Pankratova S
    Acta Neuropathol Commun; 2022 Aug; 10(1):113. PubMed ID: 35974377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Rational Structured Epitope Defines a Distinct Subclass of Toxic Amyloid-beta Oligomers.
    Silverman JM; Gibbs E; Peng X; Martens KM; Balducci C; Wang J; Yousefi M; Cowan CM; Lamour G; Louadi S; Ban Y; Robert J; Stukas S; Forloni G; Hsiung GR; Plotkin SS; Wellington CL; Cashman NR
    ACS Chem Neurosci; 2018 Jul; 9(7):1591-1606. PubMed ID: 29614860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep architecture changes in the APP23 mouse model manifest at onset of cognitive deficits.
    Van Erum J; Van Dam D; Sheorajpanday R; De Deyn PP
    Behav Brain Res; 2019 Nov; 373():112089. PubMed ID: 31325518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of STAT3 Regulates Reactive Astrogliosis and Neuronal Death Induced by AβO Neurotoxicity.
    Toral-Rios D; Patiño-López G; Gómez-Lira G; Gutiérrez R; Becerril-Pérez F; Rosales-Córdova A; León-Contreras JC; Hernández-Pando R; León-Rivera I; Soto-Cruz I; Florán-Garduño B; Campos-Peña V
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of PLCβ1 enhances endocannabinoid mobilization to restore hippocampal spike-timing-dependent potentiation and contextual fear memory impaired by Alzheimer's amyloidosis.
    Lee J; Kwag J
    Alzheimers Res Ther; 2021 Oct; 13(1):165. PubMed ID: 34625112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease.
    Hector A; Brouillette J
    Front Mol Neurosci; 2020; 13():600084. PubMed ID: 33488358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal Injections of Oligomeric Amyloid β-peptide (1-42) Induce Selective Working Memory Deficits and Long-lasting Alterations of ERK Signaling Pathway.
    Faucher P; Mons N; Micheau J; Louis C; Beracochea DJ
    Front Aging Neurosci; 2015; 7():245. PubMed ID: 26793098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective Profile of Triazole Grandisin Analogue against Amyloid-Beta Oligomer-Induced Cognitive Impairment.
    Andrade VHB; M Rodrigues EY; Dias NAF; Ferreira GFC; Carvalho DB; das Neves AR; Coronel PMV; Yonekawa MKA; Parisotto EB; Santos EAD; Souza AS; Paredes-Gamero EJ; de Sousa KS; Souza LL; Resstel LBM; Baroni ACM; Lagatta DC
    ACS Chem Neurosci; 2023 Dec; 14(24):4298-4310. PubMed ID: 38048522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.